Outcomes Based on Plasma Biomarkers for the Phase 3 CELESTIAL Trial of Cabozantinib versus Placebo in Advanced Hepatocellular Carcinoma.
Rimassa L, Kelley RK, Meyer T, Ryoo BY, Merle P, Park JW, Blanc JF, Lim HY, Tran A, Chan YW, McAdam P, Wang E, Cheng AL, El-Khoueiry AB, Abou-Alfa GK.
Rimassa L, et al. Among authors: wang e.
Liver Cancer. 2021 Dec 3;11(1):38-47. doi: 10.1159/000519867. eCollection 2022 Jan.
Liver Cancer. 2021.
PMID: 35222506
Free PMC article.